M C Minnema

Summary

Affiliation: University Medical Center Utrecht
Country: The Netherlands

Publications

  1. doi request reprint Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome
    M C Minnema
    Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands
    Bone Marrow Transplant 41:779-84. 2008
  2. ncbi request reprint New developments in the treatment of patients with multiple myeloma
    M C Minnema
    Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands
    Neth J Med 68:24-32. 2010
  3. doi request reprint Prognostic factors and outcome in relapsed multiple myeloma after nonmyeloablative allo-SCT: a single center experience
    M C Minnema
    Department of Hematology, UMC Utrecht, Utrecht, The Netherlands
    Bone Marrow Transplant 46:244-9. 2011
  4. pmc Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1
    R Oostvogels
    Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands
    Leukemia 27:642-9. 2013
  5. ncbi request reprint A survey on diagnostic methods and treatment strategies used in patients with Waldenström's macroglobulinaemia in The Netherlands
    S Klodzinska
    Department of Haematology, University Medical Centre Utrecht, Utrecht, The Netherlands
    Neth J Med 71:90-6. 2013
  6. doi request reprint Human herpes virus 6 reactivation: important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT
    P J A de Pagter
    Department of Immunology Hematology and BMT, University Medical Center Utrecht, Utrecht, The Netherlands
    Bone Marrow Transplant 48:1460-4. 2013
  7. ncbi request reprint Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment
    M C Minnema
    Department of Haematology, University Medical Center Utrecht, Utrecht, The Netherlands
    J Thromb Haemost 1:445-9. 2003
  8. doi request reprint High level of perforin expression in T cells: An early prognostic marker of the severity of herpesvirus reactivation after allogeneic stem cell transplantation in adults
    F L Pietersma
    Department of Immunology, University Medical Center Utrecht, The Netherlands
    Clin Infect Dis 50:717-25. 2010

Collaborators

Detail Information

Publications8

  1. doi request reprint Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome
    M C Minnema
    Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands
    Bone Marrow Transplant 41:779-84. 2008
    ..In conclusion, the incidence of relapse with EM disease following allogeneic NMA SCT was 20.4%. There was no negative impact of EM relapse on response rate, overall survival and progression-free survival...
  2. ncbi request reprint New developments in the treatment of patients with multiple myeloma
    M C Minnema
    Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands
    Neth J Med 68:24-32. 2010
    ..This review will focus on those studies that have changed the treatment guidelines for patients with MM...
  3. doi request reprint Prognostic factors and outcome in relapsed multiple myeloma after nonmyeloablative allo-SCT: a single center experience
    M C Minnema
    Department of Hematology, UMC Utrecht, Utrecht, The Netherlands
    Bone Marrow Transplant 46:244-9. 2011
    ..Six patients (16%) have died from treatment-related diseases. These results indicate that NMA allo-SCT is a treatment option in relapsed MM patients and that results may be improved by strategies that enhance the CR rate after allo-SCT...
  4. pmc Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1
    R Oostvogels
    Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands
    Leukemia 27:642-9. 2013
    ..Thus, with the capacity to induce relevant immunotherapeutic CTLs, it's HLA-A*02 restriction and equally balanced phenotype frequency, UTA2-1 is a highly valuable mHag to facilitate clinical application of mHag-based immunotherapy...
  5. ncbi request reprint A survey on diagnostic methods and treatment strategies used in patients with Waldenström's macroglobulinaemia in The Netherlands
    S Klodzinska
    Department of Haematology, University Medical Centre Utrecht, Utrecht, The Netherlands
    Neth J Med 71:90-6. 2013
    ..Currently, there is a wide range of therapeutic options used for the management of WM but no approved therapeutic agents are available specifically for this disease...
  6. doi request reprint Human herpes virus 6 reactivation: important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT
    P J A de Pagter
    Department of Immunology Hematology and BMT, University Medical Center Utrecht, Utrecht, The Netherlands
    Bone Marrow Transplant 48:1460-4. 2013
    ..001) and NRM (P=0.03). Regular monitoring of HHV6 reactivation after HSCT might be important in MA HSCT patients to enable early initiation of antiviral treatment or to anticipate aGVHD, all of which may improve clinical outcome. ..
  7. ncbi request reprint Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment
    M C Minnema
    Department of Haematology, University Medical Center Utrecht, Utrecht, The Netherlands
    J Thromb Haemost 1:445-9. 2003
    ..These prothrombogenic circumstances could contribute to the high incidence of VTE during treatment with thalidomide in combination with dexamethasone/chemotherapy...
  8. doi request reprint High level of perforin expression in T cells: An early prognostic marker of the severity of herpesvirus reactivation after allogeneic stem cell transplantation in adults
    F L Pietersma
    Department of Immunology, University Medical Center Utrecht, The Netherlands
    Clin Infect Dis 50:717-25. 2010
    ..Here, we studied perforin expression in CD8(+) T cells as a measure of cytotoxic T cell capacity in relation to the occurrence of viral reactivation...